Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome "BEAUTY-II"

Recruiting

Phase 4 Results N/A

Eligibility Criteria

Inclusion Criteria

- Patients who can undergo percutaneous coronary intervention with Biomatrix stent with no history of TIA or stroke,
- 75 years old or younger,
- body weight of 60 kg or more and diagnosed with acute coronary syndrome

Exclusion Criteria

- Patients with history of TIA or stroke,
- 75 years old or older,
- body weight of 60 kg or under,
- hypersensitivity to or contraindicated for heparin, aspirin, clopidogrel, prasugrel or contrast media